FdaApplication
ANDA 216921
Identifiers
- fda_app_no: ANDA216921
Properties
| Property | Value |
|---|---|
| applicant_name | NATCO PHARMA LTD |
| application_type | ANDA |
| approval_date | 2026-02-17 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| IDELALISIB | IDELALISIB | 100MG | TABLET;ORAL |
| IDELALISIB | IDELALISIB | 150MG | TABLET;ORAL |
2 products